Skip to content

Comparison of three methods of pregnancy poisining diagnosis

Clinical trial to compare random urine protein-creatinine ratio and protein dip stick with 24-hour urine protein to diagnosis preeclampsia in pregnant women that are

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201102125810N1
Enrollment
86
Registered
2011-02-25
Start date
2010-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia. Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperiumm

Interventions

Intervention 1: In this study, 24-hour urine protein is measured once with special laboratory kit on all patients samples. Intervention 2: In this study, a random urine sample is taken from the patien
Diagnosis
In this study, 24-hour urine protein is measured once with special laboratory kit on all patients samples
In this study, a random urine sample is taken from the patients, in which the amount of protein and creatinine with special laboratory kit is measured.
On patients random urine samples an amount of dip stick protein is measured.

Sponsors

Vice chancellor for research, Hamedan University of Medical Sciences and Health Services
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:" Pregnant women with gestational age higher than 20 weeks that are suspicious of preeclampsia ". Exclusion criteria: Since there are lots of factors which lead to proteinuria, below patients will be discluded from the study: 1. " Patients with secondary glomerulonephropathy " a: " Diabetes mellitus " b: "Lupus " c: " Active infectious like Hepatitis B and C , Syphlis , Malaria , Endocarditis , HIV " d: " Long and digestive cancer , Lymphoma " 2. " Drug induced glomerulonephropathy " a: " Heroin " b: " NSAID usage " c: " Lithium " 3. " Tubular reasons " a: " Chronic Hypertension " " And of those patients who did not collect their 24-hour urine sample accordingly ". (based on 24-hour urine creatinine)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood Pressure. Timepoint: Blood pressure is measured once when the patient is visited for the first time and every 6 hours when the patient is hospitalized. Protein and creatinine are measured once in a 24-hour urine sample and once in a random urine sample. Protein is also measured using the dip stick in a random urine. Method of measurement: Blood pressure measured with mercury barometer based on " mmHg " .;Creatinine. Timepoint: Creatinine is measured once in 24-hour urine sample and random urine sample when the samples was given. Method of measurement: Creatinine is measured with special laboratory kit and it's based on " mg/dl " .;Protein. Timepoint: Protein is measured once in 24-hour urine and random urine samples when the samples were given. Method of measurement: Protein is measured with special laboratory kit. It scale in 24-hour urine sample is " mg/24h " and in random urine sample is " mg " .

Secondary

MeasureTime frame
Liver enzymes (AST-ALT-Bil). Timepoint: They're measured once. Method of measurement: They're measured with special laboratory kit.;Platelets. Timepoint: It's measured once. Method of measurement: It's measured with special laboratory kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazanin Atrvash

Hamedan university of Medical Science and Health Service

atrvash.nazanin@gmail.com/ nazaninatrvash@yahoo.com+98 21 8803 3816

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026